Quantitative washout in patients with hepatocellular carcinoma undergoing TACE: an imaging biomarker for predicting prognosis?

BACKGROUND: The delayed percentage attenuation ratio (DPAR) was recently identified as a novel predictor of an early complete response in patients with hepatocellular carcinoma (HCC) undergoing transarterial chemoembolization (TACE). In this study, we aimed to validate the role of DPAR as a predicti...

Descripción completa

Detalles Bibliográficos
Autores principales: Müller, Lukas, Hahn, Felix, Jungmann, Florian, Mähringer-Kunz, Aline, Stoehr, Fabian, Halfmann, Moritz C., Pinto dos Santos, Daniel, Hinrichs, Jan, Auer, Timo A., Düber, Christoph, Kloeckner, Roman
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8753936/
https://www.ncbi.nlm.nih.gov/pubmed/35016731
http://dx.doi.org/10.1186/s40644-022-00446-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8753936/
https://www.ncbi.nlm.nih.gov/pubmed/35016731
http://dx.doi.org/10.1186/s40644-022-00446-6

Ejemplares similares